The Scientific and Clinical Team at Ambys Medicines is responsible for driving the company's research and development efforts in regenerative and restorative liver therapies. This team integrates cutting-edge scientific research with clinical expertise to design, implement, and oversee preclinical and clinical studies. Their work involves ensuring the quality and efficacy of novel treatments, conducting bioanalytical assessments, and advancing the development of innovative therapeutic modalities like cell and gene therapy to restore liver function and prevent liver failure.
Brendan Lee
Scientific Advisor
Daniel P. Anderson
Scientific Advisor
Holger Willenbring
Scientific Advisor
Paul Kwo
Clinical Advisor
Raymond Chung
Clinical Advisor
Robert Fisher
Clinical Advisor
Scott Naugler
Clinical Advisor
Stephen Strom
Clinical Advisor
Steven D. Colquhoun
Clinical Advisor
Yury Popov
Scientific Advisor
View all